Anti-infective peptides comprising a C terminal amine group
WO2013011135A1
Ceramide c16-cer and cers6 in the treatment and diagnosis of multiple sclerosis (ms)
WO2012113733A1
Nanoparticles as mrt contrast media for the diagnosis of hepatocellular carcinoma
WO2012098143A1
Use of inhibitors of atp-sensitive potassium channels for the treatment of hearing loss
DE102011120244A1
Receiver architecture for orthogonal, multiple-input-multiple-output radar systems
EP2591782A1
Nadph oxidase 4 inhibitors and use thereof
GB201115992D0
Treatment of neuropathic pain and nerve injury by Nox4 inhibition
DE102011113283A1
Increase of lipid content in microalgae by genetic manipulation of a triacylglycerol (TAG) lipase
GB201114289D0
Flurbiprofen and related compounds for the treatment of skin diseases
DE102011076840A1
A monolithically integrated antenna and receiver circuit and THz heterodyne receiver and imaging system comprising the same and use thereof for detecting electromagnetic radiation in the THz frequency range
DE102011017208A1
Bivalirudin and other hirudin analogs for preserving cellular functionality in clinical cell therapy
DE102011001952A1
Apparatus and method for determining the coagulation time of blood
EP2505589A1
Novel sphingolipid heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
WO2011121075A1
Use of the biomarkers sflt and pigf in the diagnosis and therapy of pulmonary hypertonism
DE102010055564A1
Method and apparatus for depositing silicon on a substrate
GB201018519D0
(R)-flurbiprofen for use in the treatment of multiple sclerosis
EP2446929A1
Microvesicles derived from atheroprotective endothelial cells for the treatment and prevention of atherosclerotic diseases
DE102010017568A1
Hyperpolarization device and method for administering a hyperpolarized liquid contrast agent
DE102010028987A1
Subharmonic mixer
EP2371370A1
Antagonists of miRNA-29 expression and their use in the prevention and treatment of aortic aneurysms and atherosclerotic plaque destabilization
